Back to filter
Original filing (PDF)20250917144825NAL0000609105001
REGENERON PHARMACEUTICALS, INC.
Form 5500
FILING_RECEIVED
REGENERON PHARMACEUTICALS, INC. 401(K) SAVINGS PLAN
401(k) retirement plan
Signals · 2
1 failed disclosure22% employer stock
Active participants
11,960
Accounts w/ balance
13,884
Plan assets (EOY)
$2.6B
Net assets (EOY)
$2.6B
How this plan invests
This plan
15 pooled trusts
Schedule D
28 securities
funds · stocks · CUSIPs
Holdings are itemized directly on this plan's Schedule of Assets, below.
Plan health score (directional)
91
/ 100
Grade A
Top-tier plan health
Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.
Compliance & disclosures
85
Concentration risk
75
Total plan cost
100
Vendor stack
100
Participation health
100
Knocking points off
- 1 Schedule C provider failed to disclose compensation.
- 22% of plan in employer / sponsor stock.
Helping the score
- Below-peer total fees (2 bps vs 5 bps peer median).
Decision-maker contacts
CFO / Head of HR / Benefits Manager — verified email + LinkedIn for REGENERON PHARMACEUTICALS, INC..
Plan sponsor
Name
REGENERON PHARMACEUTICALS, INC.
EIN
13-3444607
Address
777 OLD SAW MILL RIVER ROAD · TARRYTOWN, NY · 10591
Phone
(914) 847-7400
Industry
Manufacturingsee all
Plan administrator
Same as plan sponsor.
Plan characteristics
Plan number
001
Plan year
2024
Plan year begin
2024-01-01
Tax period
2024-12-31
Filed
2025-09-17
Pension benefit codes
2E · Profit-sharing
2F · ERISA section 404(c)
2H · Partial participant-directed accounts
2J · 401(k) feature
2K · 401(m) arrangement
2S · Automatic enrollment
2T · Default investment account (QDIA)
3F · Sponsor used leased employees
3D · Pre-approved plan (master / prototype / VS)
2R · Participant-directed brokerage (SDBA)
Audit & trust (Schedule H)
Auditor
CROWE LLP
Trustee / custodian
—
Trustee phone
—
Service providers (Schedule C)
3 rowsRecordkeeper
1| Name | EIN | Location | Relation | Direct comp | Indirect comp |
|---|---|---|---|---|---|
| FIDELITY INVESTMENTS INSTITUTIONAL | 04-2647786 | — | RECORDKEEPER | $397K | — |
Advisor / Consultant
1| Name | EIN | Location | Relation | Direct comp | Indirect comp |
|---|---|---|---|---|---|
| CAPFINANCIAL PARTNERS, LLC | 26-0058143 | — | INVESTMENT ADVISOR | $95K | — |
Accountant / Auditor
1| Name | EIN | Location | Relation | Direct comp | Indirect comp |
|---|---|---|---|---|---|
| CROWE LLP | 35-0921680 | — | ACCOUNTANT | $46K | — |
Failed / refused disclosures (Sched C Part 2)
| Provider | Nondisclosure info |
|---|---|
| — | — |
Investments
14 direct securities · 15 pooled funds· $2.8B(100% of reported assets)
Rows tagged as a trust or pooled fund hold many underlying securities. Click one to drill into its own Schedule of Assets — where the individual funds, shares, and CUSIPs live.
Uncategorized
$1.5B
14 holdings
Common Collective Trust
$1.3B
15 holdings
| PI | Investment | Type | Shares / units | Cost | Current value | % of plan |
|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. Common Stock | — | — | $340.7M | $560.4M | 21.5% | |
| JPMorgan Large Cap Grow th Fund Class R6 | — | — | — | $279.0M | 10.7% | |
| JPM LG CP GRTH CF-A JP MORGAN CHASE BANK, N.A. · EIN 45-4173185 / PN 001 | Common Collective Trust | — | — | $279.0M | 10.7% | |
| Vanguard Institutional Index Fund Institutional | — | — | — | $254.5M | 9.8% | |
| VANGUARD TRGET 2045 VANGUARD FIDUCIARY TRUST COMPANY · EIN 90-6083972 / PN 001 | Common Collective Trust | — | — | $150.4M | 5.8% | |
| VANGUARD TRGET 2040 VANGUARD FIDUCIARY TRUST COMPANY · EIN 90-6083974 / PN 001 | Common Collective Trust | — | — | $140.7M | 5.4% | |
| VANGUARD TRGET 2050 VANGUARD FIDUCIARY TRUST COMPANY · EIN 90-6083970 / PN 001 | Common Collective Trust | — | — | $135.4M | 5.2% | |
| VANGUARD TRGET 2035 VANGUARD FIDUCIARY TRUST COMPANY · EIN 90-6083976 / PN 001 | Common Collective Trust | — | — | $131.4M | 5.0% | |
| VANGUARD TRGET 2055 VANGUARD FIDUCIARY TRUST COMPANY · EIN 27-6715091 / PN 001 | Common Collective Trust | — | — | $128.9M | 4.9% | |
| VANGUARD TRGET 2030 VANGUARD FIDUCIARY TRUST COMPANY · EIN 90-6083978 / PN 001 | Common Collective Trust | — | — | $94.1M | 3.6% | |
| VANGUARD TRGET 2060 VANGUARD FIDUCIARY TRUST COMPANY · EIN 45-3799419 / PN 001 | Common Collective Trust | — | — | $88.5M | 3.4% | |
| John Hancock Disciplined Value Fund Class R6 | — | — | — | $72.8M | 2.8% | |
| Vanguard Extended Market Index Fund Admiral Shares | — | — | — | $58.9M | 2.3% | |
| American Funds EuroPacific Grow th Fund Class R-6 | — | — | — | $52.6M | 2.0% | |
| American Funds Small Cap World Fund Class R-6 | — | — | — | $43.5M | 1.7% | |
| VANGUARD TRGET 2025 VANGUARD FIDUCIARY TRUST COMPANY · EIN 90-6083980 / PN 001 | Common Collective Trust | — | — | $41.9M | 1.6% | |
| Dodge & Cox Dodge & Cox Income X | — | — | — | $37.1M | 1.4% | |
| Vanguard Total International Stock Index Fund Admiral | — | — | — | $36.1M | 1.4% | |
| Vanguard Total Bond Market Index Fund Admiral Shares | — | — | — | $31.3M | 1.2% | |
| MORLEY SV 20 - II PRINCIPAL GLOBAL INVESTORS TRUST CO · EIN 93-6274329 / PN 001 | Common Collective Trust | — | — | $29.3M | 1.1% | |
| Delaw are Funds Small Cap Value Fund Institutional | — | — | — | $27.7M | 1.1% | |
| Fidelity Money Market Fund | — | — | — | $26.2M | 1.0% | |
| VANGUARD TRGET 2065 VANGUARD FIDUCIARY TRUST COMPANY · EIN 82-6194314 / PN 001 | Common Collective Trust | — | — | $23.3M | 0.9% | |
| SMCP Value II R6 | — | — | — | $21.4M | 0.8% | |
| MFS Mid Cap Value Fund Class R6 | — | — | — | $21.4M | 0.8% | |
| MFS MID CAP VALUE CT GREAT GRAY TRUST COMPANY · EIN 38-4139822 / PN 616 | Common Collective Trust | — | — | $19.5M | 0.7% | |
| VANGUARD TRGET 2020 VANGUARD FIDUCIARY TRUST COMPANY · EIN 90-6083982 / PN 001 | Common Collective Trust | — | — | $11.0M | 0.4% | |
| VANGUARD TRGET INC VANGUARD FIDUCIARY TRUST COMPANY · EIN 90-6083967 / PN 001 | Common Collective Trust | — | — | $5.0M | 0.2% | |
| VANGUARD TARGET 2070 VANGUARD FIDUCIARY TRUST COMPANY · EIN 88-6095930 / PN 001 | Common Collective Trust | — | — | $701K | <0.1% |